BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q4 2024 vs. Q3 2024
How the institutions holding BIO-TECHNE Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 564 | 11 | 577 | +24 |
| Shares | 154.7M | 722.0K | 156.8M | +2.80M (+1.8%) |
| Value | $12.4B | $56.5M | $11.3B | −$1.01B (−8.2%) |
11 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (75)
Institutions that held BIO-TECHNE Corp at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (51)
Institutions that held BIO-TECHNE Corp at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (11)
Institutions that held BIO-TECHNE Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 356,597 | $28.5M |
| Eagle Asset Management Inc | 299,707 | $22.8M |
| LWMG, LLC | 15,285 | $1.22M |
| Rakuten Investment Management, Inc. | 8,929 | $702.9K |
| PEAK6 Investments LLC | 8,732 | $697.9K |
| Sweet Financial Partners, LLC | 8,680 | $693.8K |
| Raymond James Trust N.A. | 8,249 | $659.3K |
| Raymond James Financial Services Advisors, Inc. | 8,150 | $651.4K |
| B. Metzler seel. Sohn & Co. Holding AG | 3,997 | $319.5K |
| SpiderRock Advisors, LLC | 3,715 | $296.9K |
| First Personal Financial Services | 2 | $160 |